Natco Pharma's Generic Semaglutide to Hit Indian Market in March Parthika Patel14 Feb 2026 9:26 PM ISTNew Delhi: Natco Pharma Limited has received approval from the Central Drugs Standard Control Organisation (CDSCO) to manufacture and market...
Semaglutide Improves Glycemic Control in Adolescents With Obesity: Study Medha Baranwal13 Feb 2026 11:45 AM ISTUSA: A secondary analysis of the 68-week STEP TEENS trial, published in Diabetes Care, found that semaglutide 2.4 mg significantly improved insulin...
OneSource Secures Saudi Nod for Generic Ozempic, Partners Hikma for MENA Rollout Parthika Patel12 Feb 2026 11:26 PM ISTNew Delhi: OneSource Specialty Pharma Limited has received regulatory approval in Saudi Arabia to commercialise a generic version of Ozempic...
Once-Weekly Semaglutide Outperforms Daily Liraglutide for weight loss and HbA1c reduction in Diabetes Patients: Study Dr. Shravani Dali11 Feb 2026 9:00 AM ISTResearchers have found in a new real-world Pakistani cohort, once-weekly semaglutide achieved greater weight loss and HbA1c reduction than daily...
Natco Pharma Gets Court Nod to Make, Export Semaglutide for Diabetes and Obesity Markets Susmita Roy10 Feb 2026 7:32 PM ISTNew Delhi: Natco Pharma has secured regulatory clearance from the High Court to manufacture semaglutide and export the drug to select international...
Novo Nordisk Loses USD 50 Billion as Obesity Drug Price War Triggers Profit, Sales Warning sheeba farhat6 Feb 2026 11:15 AM ISTNew Delhi: Novo Nordisk's shares tumbled on Wednesday, knocking nearly USD 50 billion in value from the Danish obesity drug giant, as it warned that...
Emcure Beats 9 Rivals to Secure Second Semaglutide Brand from Novo Nordisk for India Parthika Patel5 Feb 2026 10:31 PM ISTNew Delhi: Emcure Pharmaceuticals has secured exclusive rights to market a second brand of semaglutide in India through a partnership with Novo...
SURPASS-2- Tirzepatide vs Semaglutide in Type 2 Diabetes Deeksha Bhandari4 Feb 2026 12:30 PM ISTKey Summary: In addition to meeting the primary objective of noninferiority to semaglutide in type 2 diabetes (T2D), tirzepatide, at a dose of...
Cagrilintide-Semaglutide combo Improves Weight Loss and Glycemic Control in T2DM, finds trial Dr. Kamal Kant Kohli3 Feb 2026 8:45 PM ISTTopline results from the REIMAGINE 2 trial involving 2,728 adults with type 2 diabetes inadequately controlled on metformin showed that combined...
India-EU FTA Could Reduce Drug Prices by Up to 20%, Transform Access to Biologics and Devices Susmita Roy29 Jan 2026 11:15 PM ISTNew Delhi: India's Free Trade Agreement (FTA) with the European Union is being projected as a major breakthrough for healthcare, with expectations of...
SURPASS-2: Superior HbA1c and Weight Reduction With Tirzepatide vs. Semaglutide Deeksha Bhandari29 Jan 2026 11:00 AM ISTThe SURPASS-2 trial compared three doses of tirzepatide (5 mg, 10 mg, 15 mg) with semaglutide 1 mg, in adults with type 2 diabetes who were already...
From Teriparatide to Pembrolizumab: CDSCO Clears Import of r-DNA Drugs via CT-18 Route Susmita Roy26 Jan 2026 1:58 PM ISTNew Delhi: The Central Drugs Standard Control Organisation (CDSCO) has granted multiple CT-18 approvals between January 2020 and December 2025 for...
